Martin Scheringer

But why is it relevant for the MedTech industry? And why are clients asking questions about PFAS all of a sudden? What are the risks and opportunities for MedTech companies, and above all, what should companies do today? I'm going to address these questions together with three experts.

First, with Professor Dr. Martin Scheringer from ETH Zurich.

He is one of the leading experts in PFAS and in environmental chemistry.

Arne Jaksch from Jaksch Life Science Consulting.

Companies that start creating transparency today and systematically evaluate their applications will be better prepared regardless of future regulations.

I hope I have summed up more or less what we were discussing.

I would like to thank our guests, uh, Martin Scheringer, Arne Jaksch, and Lucas Pianegonda for these exciting discussions.

And to our audience, um, thank you very much for listening.